C反应性蛋白–甘油三酯葡萄糖指数与心血管疾病风险之间的关联
The Association between C-Reactive Protein-Triglyceride-Glucose Index and the Risk of Cardiovascular Diseases
DOI: 10.12677/acm.2025.1561766, PDF,   
作者: 饶晶晶, 何 敏, 谭黎娜, 王 越, 胡良波：广西医科大学第一临床医学院，广西 南宁；曾晓聪*：广西医科大学第一临床医学院，广西 南宁；广西医科大学第一附属医院心血管内科，广西 南宁
关键词: 心血管疾病；C反应蛋白–甘油三酸酯葡萄糖指数；炎症；胰岛素抵抗；中国卫生与退休纵向研究；Cardiovascular Diseases； C-Reactive Protein-Triglyceride Glucose Index； Inflammation； Insulin Resistance； CHARLS
摘要: 目的：C-反应蛋白–甘油三酯–葡萄糖指数(CTI)已被提出作为胰岛素抵抗炎症的新生物标志物。然而，在中国人群中CTI与心血管疾病风险之间的关系仍然不清楚，旨在探讨中国普通人群中CTI与心血管疾病之间的复杂关系。方法：中国卫生与退休纵向研究(CHARLS)总共有5267名中年和老年参与者，主要终点是心血管疾病事件的发生。使用0.412 * Ln (CRP [mg/l]) + Ln (TG [mg/dl] × FPG [mg/dl])/2计算CTI。Kaplan-Meier曲线，COX比例危害模型和受限的立方样条分析用于探索CTI与心血管疾病风险之间的关联。结果：在随访期间，记录了2603例CVD病例，随着CTI四分位数(Q1→Q4)升高，心血管疾病事件数和风险比(HR)逐步递增，呈现明确的剂量–反应关系(趋势检验P < 0.001)。结论：CTI值变化与45岁及45岁以上个人的CVD风险增加显着相关，从而确认其潜在的潜力是心血管疾病风险分层的宝贵工具。
Abstract: Objective: The C-reactive protein-triglyceride-glucose index (CTI) has been proposed as a new biomarker for insulin resistance and inflammation. However, the relationship between CTI and the risk of cardiovascular diseases in the Chinese population remains unclear, aiming to explore the complex relationship between CTI and cardiovascular diseases in the general Chinese population. Method: The China Health and Retirement Longitudinal Study (CHARLS) involved a total of 5267 middle-aged and elderly participants, and the primary endpoint was the occurrence of cardiovascular disease events. CTI was calculated using 0.412 * Ln (CRP [mg/l]) + Ln (TG [mg/dl] × FPG [mg/dl])/2. The Kaplan-Meier curve, COX proportional hazards model and restricted cubic spline analysis were used to explore the association between CTI and the risk of cardiovascular diseases. Result: During the follow-up period, 2,603 cases of CVD were recorded. With the increase of the quartile of CTI (Q1→Q4), the number of cardiovascular disease events and the hazard ratio (HR) gradually increased, presenting a clear dose-response relationship (trend test P < 0.001). Conclusion: Changes in CTI values are significantly associated with an increased risk of CVD in individuals aged 45 and above, thereby confirming its potential as a valuable tool for risk stratification in CVD.
文章引用：饶晶晶, 何敏, 谭黎娜, 王越, 胡良波, 曾晓聪. C反应性蛋白–甘油三酯葡萄糖指数与心血管疾病风险之间的关联[J]. 临床医学进展, 2025, 15(6): 601-613. https://doi.org/10.12677/acm.2025.1561766

参考文献

[1] Martin, S.S., Aday, A.W., Almarzooq, Z.I., Anderson, C.A.M., Arora, P., Avery, C.L., et al. (2024) 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association. Circulation, 149, e347-e913.
[2] Liu, S., Li, Y., Zeng, X., Wang, H., Yin, P., Wang, L., et al. (2019) Burden of Cardiovascular Diseases in China, 1990-2016: Findings from the 2016 Global Burden of Disease Study. JAMA Cardiology, 4, 342-352. [Google Scholar] [CrossRef] [PubMed]
[3] Zhao, D., Liu, J., Wang, M., Zhang, X. and Zhou, M. (2018) Epidemiology of Cardiovascular Disease in China: Current Features and Implications. Nature Reviews Cardiology, 16, 203-212. [Google Scholar] [CrossRef] [PubMed]
[4] Chong, B., Jayabaskaran, J., Jauhari, S.M., Chan, S.P., Goh, R., Kueh, M.T.W., et al. (2024) Global Burden of Cardiovascular Diseases: Projections from 2025 to 2050. European Journal of Preventive Cardiology. [Google Scholar] [CrossRef] [PubMed]
[5] Roth, G.A., Abate, D., Abate, K.H., Abay, S.M., Abbafati, C., Abbasi, N., et al. (2018) Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1736-1788. [Google Scholar] [CrossRef] [PubMed]
[6] Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., et al. (2022) Aging and Aging-Related Diseases: From Molecular Mechanisms to Interventions and Treatments. Signal Transduction and Targeted Therapy, 7, Article No. 391. [Google Scholar] [CrossRef] [PubMed]
[7] Hill, M.A., Yang, Y., Zhang, L., Sun, Z., Jia, G., Parrish, A.R., et al. (2021) Insulin Resistance, Cardiovascular Stiffening and Cardiovascular Disease. Metabolism, 119, Article ID: 154766. [Google Scholar] [CrossRef] [PubMed]
[8] Tao, L., Xu, J., Wang, T., Hua, F. and Li, J. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations. Cardiovascular Diabetology, 21, Article No. 68. [Google Scholar] [CrossRef] [PubMed]
[9] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, Z., Wang, J., Li, Z., Han, Z., Miao, X., Liu, X., et al. (2021) Triglyceride Glucose Index and Carotid Atherosclerosis Incidence in the Chinese Population: A Prospective Cohort Study. Nutrition, Metabolism and Cardiovascular Diseases, 31, 2042-2050. [Google Scholar] [CrossRef] [PubMed]
[11] Jin, J., Cao, Y., Wu, L., You, X., Guo, Y., Wu, N., et al. (2018) Triglyceride Glucose Index for Predicting Cardiovascular Outcomes in Patients with Coronary Artery Disease. Journal of Thoracic Disease, 10, 6137-6146. [Google Scholar] [CrossRef] [PubMed]
[12] Won, K., Park, E.J., Han, D., Lee, J.H., Choi, S., Chun, E.J., et al. (2020) Triglyceride Glucose Index Is an Independent Predictor for the Progression of Coronary Artery Calcification in the Absence of Heavy Coronary Artery Calcification at Baseline. Cardiovascular Diabetology, 19, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[13] Fritz, J., Brozek, W., Concin, H., Nagel, G., Kerschbaum, J., Lhotta, K., et al. (2022) The Association of Excess Body Weight with Risk of ESKD Is Mediated through Insulin Resistance, Hypertension, and Hyperuricemia. Journal of the American Society of Nephrology, 33, 1377-1389. [Google Scholar] [CrossRef] [PubMed]
[14] Wu, Z., Zhou, D., Liu, Y., Li, Z., Wang, J., Han, Z., et al. (2021) Association of Tyg Index and TG/HDL-C Ratio with Arterial Stiffness Progression in a Non-Normotensive Population. Cardiovascular Diabetology, 20, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[15] Wu, Z., Yu, S., Zhang, H., Guo, Z., Zheng, Y., Xu, Z., et al. (2022) Combined Evaluation of Arterial Stiffness, Glycemic Control and Hypertension for Macrovascular Complications in Type 2 Diabetes. Cardiovascular Diabetology, 21, Article No. 262. [Google Scholar] [CrossRef] [PubMed]
[16] Ridker, P.M., Bhatt, D.L., Pradhan, A.D., Glynn, R.J., MacFadyen, J.G. and Nissen, S.E. (2023) Inflammation and Cholesterol as Predictors of Cardiovascular Events among Patients Receiving Statin Therapy: A Collaborative Analysis of Three Randomised Trials. The Lancet, 401, 1293-1301. [Google Scholar] [CrossRef] [PubMed]
[17] Lawler, P.R., Bhatt, D.L., Godoy, L.C., Lüscher, T.F., Bonow, R.O., Verma, S., et al. (2020) Targeting Cardiovascular Inflammation: Next Steps in Clinical Translation. European Heart Journal, 42, 113-131. [Google Scholar] [CrossRef] [PubMed]
[18] Lan, Y., Chen, G., Wu, D., Ding, X., Huang, Z., Wang, X., et al. (2023) Temporal Relationship between Atherogenic Dyslipidemia and Inflammation and Their Joint Cumulative Effect on Type 2 Diabetes Onset: A Longitudinal Cohort Study. BMC Medicine, 21, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[19] Ruan, G., Xie, H., Zhang, H., Liu, C., Ge, Y., Zhang, Q., et al. (2022) A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients with Cancer. Frontiers in Endocrinology, 13, Article 905266. [Google Scholar] [CrossRef] [PubMed]
[20] Huang, C., You, H., Zhang, Y., Li, Z., Li, M., Feng, X., et al. (2024) Association between C-Reactive Protein-Triglyceride Glucose Index and Depressive Symptoms in American Adults: Results from the NHANES 2005 to 2010. BMC Psychiatry, 24, Article No. 890. [Google Scholar] [CrossRef] [PubMed]
[21] Zhao, D. (2023) Value of C-Reactive Protein-Triglyceride Glucose Index in Predicting Cancer Mortality in the General Population: Results from National Health and Nutrition Examination Survey. Nutrition and Cancer, 75, 1934-1944. [Google Scholar] [CrossRef] [PubMed]
[22] Xu, M., Zhang, L., Xu, D., Shi, W. and Zhang, W. (2024) Usefulness of C-Reactive Protein-Triglyceride Glucose Index in Detecting Prevalent Coronary Heart Disease: Findings from the National Health and Nutrition Examination Survey 1999-2018. Frontiers in Cardiovascular Medicine, 11, Article 1485538. [Google Scholar] [CrossRef] [PubMed]
[23] Zhao, Y., Hu, Y., Smith, J.P., Strauss, J. and Yang, G. (2012) Cohort Profile: The China Health and Retirement Longitudinal Study (CHARLS). International Journal of Epidemiology, 43, 61-68. [Google Scholar] [CrossRef] [PubMed]
[24] ElSayed, N.A., Aleppo, G., Aroda, V.R., Bannuru, R.R., Brown, F.M., Bruemmer, D., et al. (2023) Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023; 46(suppl. 1): s19-s40. Diabetes Care, 46, 1715-1715. [Google Scholar] [CrossRef] [PubMed]
[25] Cui, C., Liu, L., Qi, Y., Han, N., Xu, H., Wang, Z., et al. (2024) Joint Association of Tyg Index and High Sensitivity C-Reactive Protein with Cardiovascular Disease: A National Cohort Study. Cardiovascular Diabetology, 23, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
[26] Park, B., Lee, Y., Lee, H.S. and Jung, D. (2020) The Triglyceride-Glucose Index Predicts Ischemic Heart Disease Risk in Koreans: A Prospective Study Using National Health Insurance Service Data. Cardiovascular Diabetology, 19, Article No. 210. [Google Scholar] [CrossRef] [PubMed]
[27] Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F. and Hadaegh, F. (2020) The Impact of Triglyceride-Glucose Index on Incident Cardiovascular Events during 16 Years of Follow-Up: Tehran Lipid and Glucose Study. Cardiovascular Diabetology, 19, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[28] Tian, X., Zuo, Y., Chen, S., Liu, Q., Tao, B., Wu, S., et al. (2021) Triglyceride-Glucose Index Is Associated with the Risk of Myocardial Infarction: An 11-Year Prospective Study in the Kailuan Cohort. Cardiovascular Diabetology, 20, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[29] Hong, S., Han, K. and Park, C. (2020) The Triglyceride Glucose Index Is a Simple and Low-Cost Marker Associated with Atherosclerotic Cardiovascular Disease: A Population-Based Study. BMC Medicine, 18, Article No. 361. [Google Scholar] [CrossRef] [PubMed]
[30] Gao, J., Hao, Q., Gao, M., Zhang, K., Li, X., Wang, J., et al. (2021) Triglyceride-Glucose Index in the Development of Peripheral Artery Disease: Findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovascular Diabetology, 20, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
[31] Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. [Google Scholar] [CrossRef] [PubMed]
[32] Huang, Z., Ding, X., Yue, Q., Wang, X., Chen, Z., Cai, Z., et al. (2022) Triglyceride-Glucose Index Trajectory and Stroke Incidence in Patients with Hypertension: A Prospective Cohort Study. Cardiovascular Diabetology, 21, Article No. 141. [Google Scholar] [CrossRef] [PubMed]
[33] Li, H., Chen, S., Qian, F., Tian, X., Zuo, Y., Li, X., et al. (2022) Triglyceride-Glucose Index Variability and Incident Cardiovascular Disease: A Prospective Cohort Study. Cardiovascular Diabetology, 21, Article No. 105. [Google Scholar] [CrossRef] 
[34] Xu, X., Huang, R., Lin, Y., Guo, Y., Xiong, Z., Zhong, X., et al. (2022) High Triglyceride-Glucose Index in Young Adulthood Is Associated with Incident Cardiovascular Disease and Mortality in Later Life: Insight from the CARDIA Study. Cardiovascular Diabetology, 21, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[35] Yan, Y., Wang, D., Sun, Y., Ma, Q., Wang, K., Liao, Y., et al. (2022) Triglyceride-Glucose Index Trajectory and Arterial Stiffness: Results from Hanzhong Adolescent Hypertension Cohort Study. Cardiovascular Diabetology, 21, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[36] Wu, Z., Zhou, D., Liu, Y., Li, Z., Wang, J., Han, Z., et al. (2021) Association of TyG Index and TG/HDL-C Ratio with Arterial Stiffness Progression in a Non-Normotensive Population. Cardiovascular Diabetology, 20, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[37] Yousuf, O., Mohanty, B.D., Martin, S.S., Joshi, P.H., Blaha, M.J., Nasir, K., et al. (2013) High-Sensitivity C-Reactive Protein and Cardiovascular Disease. Journal of the American College of Cardiology, 62, 397-408. [Google Scholar] [CrossRef] [PubMed]
[38] Buckley, D.I., Fu, R., Freeman, M., Rogers, K. and Helfand, M. (2009) C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-Analyses for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151, 483-495. [Google Scholar] [CrossRef] [PubMed]
[39] Dong, Y., Wang, X., Zhang, L., Chen, Z., Zheng, C., Wang, J., et al. (2018) High-Sensitivity C Reactive Protein and Risk of Cardiovascular Disease in China-CVD Study. Journal of Epidemiology and Community Health, 73, 188-192. [Google Scholar] [CrossRef] [PubMed]

为你推荐